Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

By B. Tan, Laura Birdsell, Lisa Martin, Vickie E. Baracos, K. Fearon. Clinical Cancer Research, 2009

632 citations recorded by the source corpus.

Subfields: Geriatrics and Gerontology, Oncology, Physiology

View Paper: https://www.semanticscholar.org/paper/a4987b164e77c56d1457b3349a2c99c67c0d0734

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. K. Fearon
2. D. Glass

Citations in the corpus

• Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. (2016, background): “Tan (2009) [29] Pancreatic cancer Metastatic/ advanced 111 64.”
• Cancer cachexia: mediators, signaling, and metabolic pathways. (2012, background): “Approximately 40% of overweight or obese patients with advanced pancreatic cancer have significant skeletal muscle wasting and this ‘‘myopenic or sarcopenic obesity’’ is an independent risk factor for accelerated demise (Tan et al., 2009).”